Difference between revisions of "COVID-19 Protein"
(Created page with "Protein mapping finds 69 potential treatments for COVID-19 Many are FDA-approved drugs that could be repurposed by Leigh Krietsch Boerner MARCH 26, 2020 | APPEARED IN VOLUME 9...") |
|||
| Line 1: | Line 1: | ||
| + | |||
| + | ==Videos== | ||
| + | [https://youtu.be/Xuc9D4LVJdg Animation of SARS-CoV-2 entry into human host-cell.] | ||
| + | |||
| + | ==Coronavirus Structural Task Force== | ||
| + | https://insidecorona.net/ | ||
| + | |||
| + | ==C&EN Articles== | ||
Protein mapping finds 69 potential treatments for COVID-19 | Protein mapping finds 69 potential treatments for COVID-19 | ||
Many are FDA-approved drugs that could be repurposed | Many are FDA-approved drugs that could be repurposed | ||
Revision as of 13:30, 18 April 2021
Videos
Animation of SARS-CoV-2 entry into human host-cell.
C&EN Articles
Protein mapping finds 69 potential treatments for COVID-19 Many are FDA-approved drugs that could be repurposed by Leigh Krietsch Boerner MARCH 26, 2020 | APPEARED IN VOLUME 98, ISSUE 12
UT Austin and Mount Sinai partner to create low-cost COVID-19 vaccine Clinical trials begin with the second generation of the SARS-CoV-2 spike protein, called HexaPro by Ryan Cross APRIL 8, 2021 | APPEARED IN VOLUME 99, ISSUE 13
8 tools that helped us tackle the coronavirus In the past year, researchers worked at a breakneck pace to understand, diagnose, treat, and prevent COVID-19. These technologies were critical to their success by Ryan Cross , Laura Howes , Megha Satyanarayana JANUARY 25, 2021 | APPEARED IN VOLUME 99, ISSUE 3
The tiny tweak behind COVID-19 vaccines Prepandemic coronavirus research by Jason McLellan and Barney Graham led to a trick for stabilizing the prefusion form of spike proteins by Ryan Cross SEPTEMBER 29, 2020 | APPEARED IN VOLUME 98, ISSUE 38